Skip to main content
. 2021 Jun 11;5(8):559–568. doi: 10.1016/S2352-4642(21)00134-6

Table 1.

Demographic and clinical characteristics of children with quantitative RT-PCR-confirmed SARS-CoV-2 infection

Patients (n=11 613)
Age, years
Median (IQR) 5·1 (1·0–14·3)
Mean (SD) 7·5 (6·9)
<2 4051 (34·9%)
2–11 3973 (34·2%)
12–19 3589 (30·9%)
Sex
Male 6032/11 600 (52·0%)
Female 5568/11 600 (48·0%)
Macroregion
Southeast 4065/11 613 (35·0%)
South 963/11 613 (8·3%)
Central-West 1356/11 613 (11·7%)
Northeast 3388/11 613 (29·2%)
North 1841/11 613 (15·9%)
Ethnicity
White 3191/9181 (34·8%)
Black or Brown 5784/9181 (63·0%)
Asian 79/9181 (0·9%)
Indigenous 127/9181 (1·4%)
Signs and symptoms at presentation
Fever 7604/10 212 (74·5%)
Cough 6673/9905 (67·4%)
Respiratory distress 5056/9296 (54·4%)
Oxygen saturation <95% 3685/8967 (41·1%)
Dyspnoea 5527/9601 (57·6%)
Odynophagia 2038/8512 (23·9%)
Anosmia 336/4601 (7·3%)
Ageusia 316/4600 (6·9%)
Diarrhoea 1800/8619 (20·9%)
Vomiting 1983/8651 (22·9%)
Abdominal pain 668/4767 (14·0%)
Number of comorbidities
0 8352/11 613 (71·9%)
1 2780/11 613 (23·9%)
2 403/11 613 (3·5%)
≥3 78/11 613 (0·7%)
Type of comorbidity
Asthma 867/11 613 (7·5%)
Pulmonary disease 240/11 613 (2·1%)
Neurological disorder 706/11 613 (6·1%)
Malignancy 581/11 613 (5·0%)
Heart disease 379/11 613 (3·3%)
Haematological disease 269/11 613 (2·3%)
Kidney disease 173/11 613 (1·5%)
Diabetes 210/11 613 (1·8%)
Obesity 162/11 613 (1·4%)
Syndrome or chromosomal aberration 219/11 613 (1·9%)

Data are n/N (%) of those with available data. For comorbidities, we assumed missing data to indicate the absence of the given clinical condition.